Results 21 to 30 of about 1,353,360 (263)

EXPRESS: Statement on imaging and pulmonary hypertension from the Pulmonary Vascular Research Institute (PVRI) [PDF]

, 2019
Pulmonary hypertension is highly heterogeneous and despite treatment advances it remains a life shortening condition. There have been significant advances in imaging technologies, but despite evidence of their potential clinical utility practice remains
Swift, Andrew J., van Beek, Edwin, Olschewski, H., Horst Olschewski, Kiely, D., Screaton, Nicholas J, Michal Schafer, Rahaghi, F., David G. Kiely, Rebecca Vandepool, Tawhai, M., Mazurek, Jeremy, Rahaghi, Farbod N., Vogel-Claussen, J., Swift, Andrew, Levin, David L., Tawhai, Merryn, Ivy, David D, Andrew J. Swift, Swift, A., Van Beek, Edwin Jr, Angela Lungu, Schiebler, Mark, Schiebler, M., Bwika, J., Jone, P.-N., Dunbar Ivy, Kawut, S.M., Peacock, Andrew J., Stephen J. Wort, Kiely, David, Levin, D., Wild, J., David L. Levin, Puri, G D, Wild, Jim M, Olschewski, Horst, Schafer, M., Vanderpool, R.R., Vonk-Noordegraaf, Anton, G.D. Puri, Wort, John, Peacock, A., Hassoun, Paul M, Hassoun, Paul, Hassoun, Paul M., Jone, Pei-Ni, Lungu, Angela, Vanderpool, Rebecca R, Moledina, S., Bwika, Jumaa, Schiebler, Mark L, Kiely, David G., Shahin Moledina, Farbod N. Rahaghi, Jim Lordan, Levin, David, Jens Vogel‐Claussen, Kawut, Steven M, Rahaghi, Farbod N, Wort, J., Ivy, D.D., Wild, Jim, Pei‐Ni Jone, Kawut, Steven M., Andrew J. Peacock, Puri, Goverdhan Dutt, Mazurek, J., Jumaa Bwika, Lordan, Jim, Zhao, Lan, Tawhi, Merryn, Dunbar, Ivy, Van Beek, E.J., Mazurek, Jeremy A, Screaton, Nicholas, Vonk-Noordegraaf, A., Rahaghi, Farbod, Steven M. Kawut, Zhao, L., Anton Vonk‐Noordegraaf, Wort, Stephen J., Vandepool, Rebecca, Ivy, Dunbar, Wort, S John, Lordan, J., Wild, Jim M., Moledina, Shahin, van Beek, Edwin J. R., Schafer, Michal, Kiely, David G, Paul M. Hassoun, Jim M. Wild, Swift, Andrew J, Puri, G. D., Vogel-Claussen, Jens, Jeremy A. Mazurek, Lungu, A., Puri, G.D., Screaton, N., Mazurek, Jeremy A., Nicholas Screaton, Merryn Tawhai, Hassoun, P., Mark Schiebler, Peacock, Andrew, Lan Zhao, Edwin J.R. van Beek   +107 more
core   +1 more source

Temporal Trends in Diagnostic Hemodynamics and Survival of Patients with Pulmonary Hypertension: A Single-Center Study

Life, 2023
Advances in the diagnosis and treatment of pulmonary hypertension (PH) have gradually improved the disease course. This retrospective cohort study aims to explore the diagnostic hemodynamic profile and survival of PH patients and their temporal changes ...
Georgios E. Papadopoulos, Alexandra Arvanitaki, Eleftherios Markidis, Sophia Anastasia Mouratoglou, Ioannis T. Farmakis, Panagiotis Gourgiotis, Thomas Chrysochoidis Trantas, Christos Feloukidis, Antonios Kouparanis, Matthaios Didagelos, Vasilis Grosomanidis, Antonios Ziakas, George Giannakoulas   +12 more
doaj   +1 more source

Proteogenomic Profiling of Idiopathic Pulmonary Arterial Hypertension Identifies Sex-Differential Proteins and Candidate Therapeutic Targets. [PDF]

Adv Sci (Weinh)
An integrated proteogenomic analysis of 44,137 predominantly European‐ancestry UK Biobank participants aged 40–69 years identifies 12 robust proteins associated with idiopathic pulmonary arterial hypertension. These proteins define a high‐mortality molecular endotype, support early detection and mortality prediction, reveal sex‐differential proteomic ...
Lin X, Zhang Y, Pu Y, Liu D, Lei T, Ma K, He Q, Dou Z, Liu Y, Liu D, He Y, Wang Y, Zheng X, Ma Y, Zhou J, Zhai W, Su B, Chen L, Li S.   +18 more
europepmc   +2 more sources

Chronic thromboembolic pulmonary hypertension following long-term peripherally inserted central venous catheter use

Pulmonary Circulation, 2019
A 36-year-old woman presented with recurrent pulmonary emboli (PE) despite oral anticoagulation. She was a type I diabetic with severe gastroparesis requiring insertion of multiple long-term peripherally inserted central catheters (PICC) over a 10-year ...
Abigail Masding, Stephen D. Preston, Mark Toshner, Joseph Barnett, Carl Harries, Konstantinos Dimopoulos, Aleksander Kempny, Colm McCabe, David P. Jenkins, S. John Wort, Laura C. Price   +10 more
doaj   +1 more source

Macitentan in daily clinical practice: A single centre, 1-year experience

Pulmonology, 2018
The effectiveness and safety of macitentan, a dual endothelin-receptor antagonist (ERA) approved for the treatment of pulmonary arterial hypertension (PAH), were shown in an extensive clinical trial oriented towards morbidity and mortality events.
S. Cadenas-Menéndez, P. Álvarez-Vega, J. Martín-Moreiras, M. Barreiro-Pérez, M.Á. Gómez-Sánchez, P.L. Sánchez-Fernández   +5 more
doaj   +3 more sources

Pulmonary Hypertension: Diagnosis, Management, and Treatment [PDF]

, 2019
2019-02Pulmonary hypertension (PH) is a hemodynamic state that is characterized by a resting mean pulmonary artery pressure ≧ 25 mmHg. The common forms of PH are pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH),
Okumura, Naoki, Kondo, Takahisa, Adachi, Shiro, Murohara, Toyoaki   +3 more
core   +1 more source

Pulmonary hypertension associated with left-sided heart disease

Swiss Medical Weekly, 2017
Pulmonary hypertension associated with left-sided heart disease (PH-LHD) is the most common type of pulmonary hypertension. In patients with left-sided heart disease, the presence of pulmonary hypertension is typically a marker of more advanced disease,
Micha T. Maeder, Otto D. Schoch, Rebekka Kleiner, Lucas Joerg, Daniel Weilenmann, Swiss Medical Weekly   +5 more
doaj   +1 more source

Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT)

Pulmonary Circulation, 2022
Even though pulmonary arterial hypertension (PAH) remains an incurable disease, the combination of PAH‐specific therapies allowed treatment strategies to evolve from symptom‐based ones to others that aim to move patients to low‐risk conditions ...
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi   +7 more
doaj   +1 more source

Definitions and Diagnosis of Pulmonary Hypertension [PDF]

, 2013
Pulmonary hypertension (PH) is defined by a mean pulmonary artery pressure ≥25 mm Hg at rest, measured during right heart catheterization. There is still insufficient evidence to add an exercise criterion to this definition.
Satoh, T., Bogaard, Harm Jan, Kurzyna, M., Wilkins, M.R., Frantz, R., Langleben, David, Khanna, Dinesh, Manes, Alessandra, Bogaard, H.J., Khanna, D., Badesch, David B., Hoeper, Marius M., Kurzyna, Marcin, Torres, F., Hoeper, M.M., Satoh, Toru, Wilkins, Martin R., Torres, Fernando, Condliffe, R., Langleben, D., Badesch, D.B., Frantz, Robert, Condliffe, Robin, Manes, A.   +23 more
core   +1 more source

Magnetic resonance imaging in pulmonary hypertension: an overview of current applications and future perspectives.

, 2022
Pulmonary hypertension is an heterogeneous group of diseases characterised by increased pulmonary arterial pressures which impact on the upstream right ventricle.
Chaouat, A., Schwitter, J., Aubert, J.D., Lechartier, B.   +3 more
core   +1 more source